Pancreatic Disorders & Therapy : Citations & Metrics Report
Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.
Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
30 | 28 | 9 | 1 | 7 |
Year wise citations received |
43 | 44 | 64 | 43 | 36 |
Journal total citations count | 437 |
Journal impact factor | 1.58 |
Journal 5 years impact factor | 3.08 |
Journal cite score | 3.74 |
Journal h-index | 11 |
Journal h-index since 2018 | 9 |
Important citations (368)
Commentary on “acute pancreatitis as initial demonstration of drug- induced vasculitis” |
|
current trends in pharmacological approaches for treatment and management of acute pancreatitis - a review. |
|
does pendimethalin develop in pancreatic cancer induced inflammation |
|
design, synthesis, and biological evaluation of novel 5-substituted-2-(3,4,5-trihydroxyphenyl)-1,3,4-oxadiazoles as potent antioxidants |
|
carvacrol modulates oxidative stress and decreases cell injury in pancreas of rats with acute pancreatitis |
|
antioxidant therapy in pancreatitis |
|
low dose of carvacrol prevents rat pancreas tissue damage after l-arginine application, while higher doses cause pancreatic tissue impairment |
|
trpm2 channel-mediated cell death: an important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. |
|
pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats. |
|
antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis: an updated systematic review and meta-analysis. |
|
Synthetic triterpenoid rta dh404 (cddo-dhtfea) ameliorates acute pancreatitis |
|
rcan1 is a marker of oxidative stress, induced in acute pancreatitis |
|
dclk1 regulates pluripotency and angiogenic factors via microrna-dependent mechanisms in pancreatic cancer |
|
xmd8-92 inhibits pancreatic tumor xenograft growth via a dclk1-dependent mechanism |
|
pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors |
|
role of jnk signalling and ahr in fibrosis, implications for new therapeutics |
|
novel combination therapy boosts the host immune system, destroys free radicals and targets the critical flaw in chronic pancreatic disease |
|
role of jnk signalling and ahr in fibrosis, implications for new |
|
the role of endoscopic ultrasound (eus) in the management of patients with pancreatic cancer: now bigger than ever |
|
phase i clinical trial of peptide vaccination with urlc10 and vegfr1 epitope peptides in patients with advanced gastric cancer |
|